Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation colpidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): A randomized controlled trial

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation colpidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): A randomized controlled trial. Lancet. 2006; 367:1903-1912.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.